NM
Naga Murali Mohan Prasad Chandrabhotla
About Naga Murali Mohan Prasad Chandrabhotla
Data last updated:
Naga Murali Mohan Prasad Chandrabhotla is an Additional Director at Aim Formulations Exims Private Limited (since 2021) and Director at Devi Chitranshi Pharma Private Limited (since 2024). The companies operate in Healthcare and Pharma. The largest current company by reported revenue is Aim Formulations Exims Private Limited at ₹5.7 Lakh (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 24 Nov 2021 | 2017 | ₹5.7 Lakh (FY 2019) | Active | |
| Director | 12 Feb 2024 | 2024 | Active |
Board colleagues of Naga Murali Mohan Prasad Chandrabhotla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Satyavathi Chandrabatla | 07765736 | Aim Formulations Exims Private Limited | Director |
| Lakshmana Kumar Barick | 10504952 | Devi Chitranshi Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Naga Murali Mohan Prasad Chandrabhotla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naga Murali Mohan Prasad Chandrabhotla
Naga Murali Mohan Prasad Chandrabhotla currently holds 2 directorships: Aim Formulations Exims Private Limited (Additional Director, since 24 Nov 2021, revenue ₹5.7 Lakh (FY 2019)); Devi Chitranshi Pharma Private Limited (Director, since 12 Feb 2024).
Naga Murali Mohan Prasad Chandrabhotla was first appointed on 24 Nov 2021 as Additional Director at Aim Formulations Exims Private Limited. The most recent appointment on record is 12 Feb 2024 at Devi Chitranshi Pharma Private Limited.
The current boards of Naga Murali Mohan Prasad Chandrabhotla's companies include Satyavathi Chandrabatla (Aim Formulations Exims Private Limited), Lakshmana Kumar Barick (Devi Chitranshi Pharma Private Limited).